Molecular mechanisms of ginsenoside Rp1-mediated growth arrest and apoptosis

International Journal of Molecular Medicine

Volumn 24, Issue 3, 2009, Pages 381-386

  Kumar, Ashok ^a   Kumar, Madhu ^a   Park, Tae Yoon ^b   Park, Myung Hwan ^b   Takemoto, Tadashi ^c   Terado, Tokio ^c   Kitano, Masaru ^d   Kimura, Hiroshi ^c  

^a UNIVERSITY OF RAJASTHAN   (India)

^b Ambo Institute   (South Korea)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^d MEIJI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl 2 family proteins; Cell cyle; Ginsenoside; Mitochondria

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN A; CYCLIN D1; CYCLIN E; CYTOCHROME C; GINSENOSIDE; GINSENOSIDE RP1; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG; CASPASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; CELL CYCLE; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; MITOCHONDRION; WESTERN BLOTTING;

APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BLOTTING, WESTERN; CASPASES; CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; GINSENOSIDES; HELA CELLS; HUMANS; MITOCHONDRIA; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349575430     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000243     Document Type: Article

References (32)

1. Mann J: Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2: 143-148, 2002.
2. Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780, 2003.
3. Surh YJ, Na HK and Lee SS: Transcription factors and mitogen-activated protein kinases as molecular targets for chemoprevention with anti-inflammatory phytochemicals. Biofactors 21: 103-108, 2004.
4. Wargovich MJ, Woods C, Hollis DM and Zander MF: Herbals, cancer prevention and health. J Nutr 131: 3034-3036, 2001.
5. Yun TK: Panax ginseng-non-organ-specific cancer preventive? Lancent Oncol 2: 49-55, 2001.
6. Yun TK, Choi SY and Yun HY: Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng? J Kor Med Sci 16: 19-27, 2001.
7. Yun TK, Lee YS, Lee YH, Kim SI and Yun HY: Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Kor Med Sci 16: S6-S18, 2001.
8. Yun TK: Experimental and epidemiological evidence on non-organ specific cancer preventive effect of Korean ginseng and identification of active compounds. Mutat Res 523-524: 63-74, 2003.
9. Wang CZ, Xie JT, Zhang B, Ni M, Fishbein A, Aung HH, Mehendale SA, Du W, He TC and Yuan CS: Chemopreventive effects of Panax notoginseng and its major constituents on SW480 human colorectal cancer cells. Int J Oncol 31: 1149-1156, 2007.
10. Cheng CC, Yang SM, Huang CY, Chen JC, Chang WM and Hsu SL: Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarinoma A549 cells. Cancer Chemother Pharmacol 55: 531-540, 2005.
11. Lee KY, Lee YH, Kim SI, Park JH and Lee SK: Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21 Cip/ WAF1 and down-regulating cyclin E in SK-HEP-1 cells. Anticancer Res 17: 1067-1072, 1997.
12. Surh YJ, Na HK, Lee JY and Keum YS: Molecular mechanisms underlying anti-tumor promoting activities of heat-processed Panax ginseng C.A. Meyer. J Kor Med Sci 16: 38-41, 2001.
13. Surh YJ, Lee JY, Choi KJ and Ko SR: Effects of selected ginsenosides on phorbol ester-induced expression of cyclooxygenase-2 and activation of NF-κB and ERK1/2 in mouse skin. Ann NY Acad Sci 973: 396-401, 2002.
14. Ministry of Health: Rg-3 shenyi Jiaonang. In: Health News. Chinese Ministry of Health, Beijing, May, 2000.
15. Park IH, Piao LZ, Kwon SW, Lee YJ, Cho SY, Park MK and Park JH: Cytotoxic dammarane glycosides from processed ginseng. Chem Pharm Bull 50: 538-540, 2002.
16. Han BH, Park MH, Han YN, Woo LK, Sankawa U, Yahara S and Tanaka O: Degradation of ginseng saponins under mild acidic conditions. Planta Med 44: 146-149, 1982.
17. Park TY, Park MH, Shin WC, Rhee MH, Seo DW, Cho JY and Kim HN: Anti-metastatic potential of ginsenoside Rp1, a novel ginsenoside derivative. Biol Pharm Bull 31: 1802-1805, 2008.
18. Kumar A, Kumar M, Panwar M, Samarth RM, Park TY, Park MH and Kimura H: Evaluation of chemopreventive action of ginsenoside Rp1. Biofactors 26: 29-43, 2006.
19. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
20. Creagh EM, Conroy H and Martin SJ: Caspase-activation pathways in apoptosis and immunity. Immunol Rev 193: 10-21, 2003.
21. Er E, Oliver L, Cartron PE, Juin P, Manon S and Vallette FM: Mitochondria as the target of the pro-apoptotic protein Bax. Biochim Biophys Acta 1757: 1301-1311, 2006.
22. Kroemer G, Galluzzi L and Brenner C: Mitochondrial membrane permeabilization in cell death. Physiol Rev 87: 99-163, 2007.
23. Chen C, Yan C, Sun Q, Yao L, Jian Y, Lu J and Gu J: Induction of apoptosis by p110C requires mitochondrial translocation of the proapoptotic BCL-2 family member BAD. FEBS Lett 580: 813-821, 2006.
24. Nigg EA: Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17: 471-480, 1995.
25. Sherr CJ and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
26. WAF1/CIP1-induced apoptosis in human ovarian cancer cells. J Biol Chem 277: 36329-36337, 2002.
27. Levine AJ, Hu W and Feng Z: The P53 pathway: what questions remain to be explored? Cell Death Differ 13: 1027-1036, 2006.
28. WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells. Biochim Biophys Res Commun 324: 860-867, 2004.
29. Chowdhury I, Tharakan B and Bhat GK: Current concepts in apoptosis: the physiological suicide program revisited. Cell Mol Biol Lett 11: 506-525, 2006.
30. Kumar S: Caspase function in programmed cell death. Cell Death Differ 14: 32-43, 2007.
31. Ashkenazi A and Dixit VM: Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
32. Thomadaki H and Scorilas A: Bcl2 family of apoptosis-related genes: functions and clinical implications in cancer. Crit Rev Clin Lab Sci 43: 1-67, 2006.